Metastatic Breast Cancer Day (October 13): Its History and Significance
Metastatic Breast Cancer Day, observed on October 13th, is a day dedicated to raising awareness about a particularly challenging form of breast cancer—one that has spread beyond the breast to other parts of the body. First established by patient advocacy groups, this day aims to bring attention to the unique struggles faced by those living with metastatic breast cancer, or Stage IV breast cancer, which often receives less focus compared to early-stage diagnoses. The day highlights the need for continued research, support, and education while honoring those who have faced or are currently facing this diagnosis. Since its inception, it has grown into an important reminder of the ongoing fight to improve outcomes and find a cure.
By Ramon Diaz | Editorial Director of MammogramMe
Published October 13, 2024
Sunday Special
The History of Metastatic Breast Cancer Day
-
Metastatic Breast Cancer Day was first established in 2009 by METAvivor, a patient-led advocacy organization focused on metastatic breast cancer. This initiative sought to fill a gap in breast cancer awareness campaigns, which often emphasized early detection and survivorship, leaving the stories and needs of those living with metastatic disease underrepresented. METAvivor and other advocacy groups have since worked to build momentum around this day, aiming to draw attention to the urgent need for more research funding, new treatment options, and better support for those facing Stage IV breast cancer. Over the years, the day has become a significant part of Breast Cancer Awareness Month, with growing recognition from healthcare organizations, researchers, and policymakers.
The Importance of Metastatic Breast Cancer Day
-
Metastatic Breast Cancer Day is crucial because it shines a light on the most advanced and aggressive form of breast cancer. In the United States alone, it is estimated that about 43,000 people will die from breast cancer, with metastasis estimated to have a large role in these deaths. Furthermore, Research shows that about 30% of early-detected breast cancer cases return as metastatic cases. Therefore, despite innovations in early detection, metastatic forms of breast cancer persist. While much of the breast cancer conversation centers on early detection and survivorship, metastatic breast cancer remains incurable, requiring continuous treatment and lifelong management. This day emphasizes the need for more research to develop treatments that not only extend life but also improve quality of life for those living with metastatic breast cancer. This day also helps to raise funds for this research through a campaign spearheaded by METAVivor. By dedicating a day to focus on this stage of the disease, advocates hope to foster greater understanding, increase funding for research, and ensure that metastatic breast cancer patients receive the care, support, and attention they deserve.
This article primarily uses research from: